CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,490,000 shares, a growth of 15.5% from the July 15th total of 1,290,000 shares. Approximately 15.4% of the shares of the company are short sold. Based on an average daily trading volume, of 4,530,000 shares, the days-to-cover ratio is currently 0.3 days.
CERo Therapeutics Stock Performance
NASDAQ CERO remained flat at $0.15 on Friday. 1,365,015 shares of the company traded hands, compared to its average volume of 7,944,116. CERo Therapeutics has a 1-year low of $0.12 and a 1-year high of $12.80. The company’s fifty day simple moving average is $0.26.
About CERo Therapeutics
Featured Articles
- Five stocks we like better than CERo Therapeutics
- With Risk Tolerance, One Size Does Not Fit All
- This Small Cap Wealth Management Stock Could Provide Big Returns
- 3 Fintech Stocks With Good 2021 Prospects
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MarketBeat Week in Review – 8/12 – 8/16
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.